13F
中

PNTG PENNANT GROUP INC/THE

2026Q1 · CUSIP 70805E109 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
179
Δ holders QoQ
-6
Breadth percentile
Top 80%
Whale holders
93
Δ whales
-4
Inst. holding value
$864M
New positions
24
Closed positions
30
Price momentum (1Q)
+11.0%
Put / Call
0/2

Breadth history (34 quarters)

2019Q4: Δ+138 · h=145 2020Q1: Δ-28 · h=117 2020Q2: Δ+0 · h=117 2020Q3: Δ+27 · h=144 2020Q4: Δ+10 · h=154 2021Q1: Δ+6 · h=160 2021Q2: Δ-10 · h=150 2021Q3: Δ-15 · h=135 2021Q4: Δ+1 · h=136 2022Q1: Δ-1 · h=135 2022Q2: Δ-13 · h=122 2022Q3: Δ+1 · h=123 2022Q4: Δ+9 · h=132 2023Q1: Δ-4 · h=128 2023Q2: Δ+4 · h=132 2023Q3: Δ-6 · h=126 2023Q4: Δ+17 · h=143 2024Q1: Δ+6 · h=149 2024Q2: Δ+2 · h=151 2024Q3: Δ+20 · h=171 2024Q4: Δ+15 · h=186 2025Q1: Δ-3 · h=183 2025Q2: Δ-8 · h=175 2025Q3: Δ+14 · h=189 2025Q4: Δ-4 · h=185 2026Q1: Δ-6 · h=179 2019Q4: holders=145 2020Q1: holders=117 2020Q2: holders=117 2020Q3: holders=144 2020Q4: holders=154 2021Q1: holders=160 2021Q2: holders=150 2021Q3: holders=135 2021Q4: holders=136 2022Q1: holders=135 2022Q2: holders=122 2022Q3: holders=123 2022Q4: holders=132 2023Q1: holders=128 2023Q2: holders=132 2023Q3: holders=126 2023Q4: holders=143 2024Q1: holders=149 2024Q2: holders=151 2024Q3: holders=171 2024Q4: holders=186 2025Q1: holders=183 2025Q2: holders=175 2025Q3: holders=189 2025Q4: holders=185 2026Q1: holders=179 -138 -69 +0 +69 +138 105152199 19Q420Q321Q222Q122Q423Q324Q225Q125Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 3 lit events

Period Percentile Next-1Q return Next-2Q return
2024Q3 Top 17% -20.7% -11.2%
2020Q3 Top 8% +13.9% -35.0%
2019Q4 Top 2% -16.4% +23.9%

Options Sentiment

Put holders
0
QoQ: 0
Call holders
2
QoQ: +2

See methodology →

Fundamentals

PE (TTM)
45.5
EPS (TTM)
$0.86
EPS YoY
+13.2%
Revenue (TTM)
$1.0B
Revenue YoY
+36.8%
Quarterly Revenue & EPS (4Y)
2022-06-30: $116M 2022-09-30: $118M 2022-12-31: $125M 2023-03-31: $126M 2023-06-30: $132M 2023-09-30: $140M 2023-12-31: $146M 2024-03-31: $157M 2024-06-30: $169M 2024-09-30: $181M 2024-12-31: $189M 2025-03-31: $210M 2025-06-30: $220M 2025-09-30: $229M 2025-12-31: $289M 2026-03-31: $285M 2022-06-30: EPS -0.09 2022-09-30: EPS 0.16 2022-12-31: EPS 0.12 2023-03-31: EPS 0.06 2023-06-30: EPS 0.09 2023-09-30: EPS 0.15 2023-12-31: EPS 0.14 2024-03-31: EPS 0.16 2024-06-30: EPS 0.18 2024-09-30: EPS 0.20 2024-12-31: EPS 0.16 2025-03-31: EPS 0.22 2025-06-30: EPS 0.20 2025-09-30: EPS 0.17 2025-12-31: EPS 0.25 2026-03-31: EPS 0.24 0M 145M 289M $M -0.10 0.09 0.28 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 38 2023-03-31: PE 49.32023-06-30: PE 27.92023-09-30: PE 30.32023-12-31: PE 36.72024-03-31: PE 42.62024-06-30: PE 50.42024-09-30: PE 46.22024-12-31: PE 372025-03-31: PE 39.82025-06-30: PE 32.42025-09-30: PE 33.22025-12-31: PE 38.12026-03-31: PE 41.3 25 39 53 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)